TRIM37 could promote the proliferation and repressed the apoptosis of T-ALL cells, indicating the oncogenic effect of TRIM37 on the development of T-ALL, and TRIM37 might be a potential therapeutic target for T-ALL clinical treatment. The gene discussed is TRIM37; the disease is acute lymphoblastic leukemia.